BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20921438)

  • 1. Chemokine receptor 7 knockout attenuates atherosclerotic plaque development.
    Luchtefeld M; Grothusen C; Gagalick A; Jagavelu K; Schuett H; Tietge UJ; Pabst O; Grote K; Drexler H; Förster R; Schieffer B
    Circulation; 2010 Oct; 122(16):1621-8. PubMed ID: 20921438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine H1 receptor promotes atherosclerotic lesion formation by increasing vascular permeability for low-density lipoproteins.
    Rozenberg I; Sluka SH; Rohrer L; Hofmann J; Becher B; Akhmedov A; Soliz J; Mocharla P; Borén J; Johansen P; Steffel J; Watanabe T; Lüscher TF; Tanner FC
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):923-30. PubMed ID: 20203300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging role of chemokine receptor 7 in atherosclerosis.
    Schieffer B; Luchtefeld M
    Trends Cardiovasc Med; 2011 Nov; 21(8):211-6. PubMed ID: 22902067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses.
    Höpken UE; Droese J; Li JP; Joergensen J; Breitfeld D; Zerwes HG; Lipp M
    Eur J Immunol; 2004 Feb; 34(2):461-70. PubMed ID: 14768051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells.
    Schneider MA; Meingassner JG; Lipp M; Moore HD; Rot A
    J Exp Med; 2007 Apr; 204(4):735-45. PubMed ID: 17371928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR7 regulates lymphocyte egress and recirculation through body cavities.
    Höpken UE; Winter S; Achtman AH; Krüger K; Lipp M
    J Leukoc Biol; 2010 Apr; 87(4):671-82. PubMed ID: 20028772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
    Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
    Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR7 deficiency on dendritic cells enhances fungal clearance in a murine model of pulmonary invasive aspergillosis.
    Hartigan AJ; Westwick J; Jarai G; Hogaboam CM
    J Immunol; 2009 Oct; 183(8):5171-9. PubMed ID: 19783686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental autoimmune encephalomyelitis develops in CC chemokine receptor 7-deficient mice with altered T-cell responses.
    Pahuja A; Maki RA; Hevezi PA; Chen A; Verge GM; Lechner SM; Roth RB; Zlotnik A; Alleva DG
    Scand J Immunol; 2006 Oct; 64(4):361-9. PubMed ID: 16970675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
    Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-1/B7-2 costimulation regulates plaque antigen-specific T-cell responses and atherogenesis in low-density lipoprotein receptor-deficient mice.
    Buono C; Pang H; Uchida Y; Libby P; Sharpe AH; Lichtman AH
    Circulation; 2004 Apr; 109(16):2009-15. PubMed ID: 15096453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization.
    Damås JK; Smith C; Øie E; Fevang B; Halvorsen B; Waehre T; Boullier A; Breland U; Yndestad A; Ovchinnikova O; Robertson AK; Sandberg WJ; Kjekshus J; Taskén K; Frøland SS; Gullestad L; Hansson GK; Quehenberger O; Aukrust P
    Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):614-20. PubMed ID: 17170367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCR7 mediates the migration of Foxp3+ regulatory T cells to the paracortical areas of peripheral lymph nodes through high endothelial venules.
    Ueha S; Yoneyama H; Hontsu S; Kurachi M; Kitabatake M; Abe J; Yoshie O; Shibayama S; Sugiyama T; Matsushima K
    J Leukoc Biol; 2007 Nov; 82(5):1230-8. PubMed ID: 17698914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive role of CCR7 in migration and functional activity of naive- and effector/memory-like Treg subsets.
    Menning A; Höpken UE; Siegmund K; Lipp M; Hamann A; Huehn J
    Eur J Immunol; 2007 Jun; 37(6):1575-83. PubMed ID: 17474155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice.
    van Wanrooij EJ; de Jager SC; van Es T; de Vos P; Birch HL; Owen DA; Watson RJ; Biessen EA; Chapman GA; van Berkel TJ; Kuiper J
    Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):251-7. PubMed ID: 18048768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased transplant arteriosclerosis in the absence of CCR7 is associated with reduced expression of Foxp3.
    Ensminger SM; Helm SN; Ohl L; Spriewald BM; Abele S; Wollin M; Wood KJ; Weyand M; Förster R
    Transplantation; 2008 Aug; 86(4):590-600. PubMed ID: 18724230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL19-IgG prevents allograft rejection by impairment of immune cell trafficking.
    Ziegler E; Gueler F; Rong S; Mengel M; Witzke O; Kribben A; Haller H; Kunzendorf U; Krautwald S
    J Am Soc Nephrol; 2006 Sep; 17(9):2521-32. PubMed ID: 16899521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis.
    Taleb S; Herbin O; Ait-Oufella H; Verreth W; Gourdy P; Barateau V; Merval R; Esposito B; Clément K; Holvoet P; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2691-8. PubMed ID: 17690315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo.
    Veillard NR; Steffens S; Pelli G; Lu B; Kwak BR; Gerard C; Charo IF; Mach F
    Circulation; 2005 Aug; 112(6):870-8. PubMed ID: 16061736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.